中华肿瘤杂志
中華腫瘤雜誌
중화종류잡지
CHINESE JOURNAL OF ONCOLOGY
2011年
12期
925-928
,共4页
许亚萍%毛伟敏%马胜林%蒋友华%刘金石%孙晓江
許亞萍%毛偉敏%馬勝林%蔣友華%劉金石%孫曉江
허아평%모위민%마성림%장우화%류금석%손효강
食管肿瘤%治疗%复发%预后
食管腫瘤%治療%複髮%預後
식관종류%치료%복발%예후
Esophageal neoplasms%Therapy%Recurrence%Prognosis
目的 探讨食管癌根治性治疗后局部复发患者多学科综合治疗的疗效及预后因素.方法 回顾性分析196例食管癌根治性治疗后局部复发患者的临床特点,并结合随访资料进行预后因素分析.采用Kaplan-Meier法和Log rank法比较生存率,以Cox模型进行多因素回归分析.结果 全组患者的中位生存时间为8.0个月,1、2、3年生存率分别为29.8%、5.9%和4.0%.单因素分析结果显示,复发时PS评分、首次根治性治疗后与复发的间隔时间、首次治疗方案以及复发后的治疗方案与患者的预后相关.Cox多因素回归分析的结果显示,首次治疗方案和复发后治疗方案为独立预后因素.复发后采用放化疗联合治疗、单纯放疗、单纯化疗、分子靶向治疗和对症支持治疗患者的中位生存时间分别为13.0、7.0、6.0、4.0和3.0个月(P=0.000).93例既往未曾接受过放疗而复发后行放射治疗的患者中,放疗剂量≥60 Gy者的生存时间明显长于放疗剂量<60Gy者(P =0.000).结论 首次治疗方案和复发后治疗方案为食管癌根治性治疗后复发的独立预后因素,建议对复发患者予以积极的多学科综合治疗以进一步提高疗效.对于局部复发既往未曾接受过放疗的患者,放疗剂量应该≥60Gy.食管癌根治性治疗后复发者的预后差,有必要对其他的治疗方法(如手术、靶向治疗等)做进一步探索.
目的 探討食管癌根治性治療後跼部複髮患者多學科綜閤治療的療效及預後因素.方法 迴顧性分析196例食管癌根治性治療後跼部複髮患者的臨床特點,併結閤隨訪資料進行預後因素分析.採用Kaplan-Meier法和Log rank法比較生存率,以Cox模型進行多因素迴歸分析.結果 全組患者的中位生存時間為8.0箇月,1、2、3年生存率分彆為29.8%、5.9%和4.0%.單因素分析結果顯示,複髮時PS評分、首次根治性治療後與複髮的間隔時間、首次治療方案以及複髮後的治療方案與患者的預後相關.Cox多因素迴歸分析的結果顯示,首次治療方案和複髮後治療方案為獨立預後因素.複髮後採用放化療聯閤治療、單純放療、單純化療、分子靶嚮治療和對癥支持治療患者的中位生存時間分彆為13.0、7.0、6.0、4.0和3.0箇月(P=0.000).93例既往未曾接受過放療而複髮後行放射治療的患者中,放療劑量≥60 Gy者的生存時間明顯長于放療劑量<60Gy者(P =0.000).結論 首次治療方案和複髮後治療方案為食管癌根治性治療後複髮的獨立預後因素,建議對複髮患者予以積極的多學科綜閤治療以進一步提高療效.對于跼部複髮既往未曾接受過放療的患者,放療劑量應該≥60Gy.食管癌根治性治療後複髮者的預後差,有必要對其他的治療方法(如手術、靶嚮治療等)做進一步探索.
목적 탐토식관암근치성치료후국부복발환자다학과종합치료적료효급예후인소.방법 회고성분석196례식관암근치성치료후국부복발환자적림상특점,병결합수방자료진행예후인소분석.채용Kaplan-Meier법화Log rank법비교생존솔,이Cox모형진행다인소회귀분석.결과 전조환자적중위생존시간위8.0개월,1、2、3년생존솔분별위29.8%、5.9%화4.0%.단인소분석결과현시,복발시PS평분、수차근치성치료후여복발적간격시간、수차치료방안이급복발후적치료방안여환자적예후상관.Cox다인소회귀분석적결과현시,수차치료방안화복발후치료방안위독립예후인소.복발후채용방화료연합치료、단순방료、단순화료、분자파향치료화대증지지치료환자적중위생존시간분별위13.0、7.0、6.0、4.0화3.0개월(P=0.000).93례기왕미증접수과방료이복발후행방사치료적환자중,방료제량≥60 Gy자적생존시간명현장우방료제량<60Gy자(P =0.000).결론 수차치료방안화복발후치료방안위식관암근치성치료후복발적독립예후인소,건의대복발환자여이적겁적다학과종합치료이진일보제고료효.대우국부복발기왕미증접수과방료적환자,방료제량응해≥60Gy.식관암근치성치료후복발자적예후차,유필요대기타적치료방법(여수술、파향치료등)주진일보탐색.
Objective The aim of this paper was to evaluate the treatment outcome of multimodal treatment for 196 patients with locoregional recurrent esophageal cancer after curative treatment and to determine the prognostic factors of recurrence. Methods One hundred and ninety six patients with locoregional recurrent esophageal cancer curatively treated in our hospital were included in this study.Kaplan-Meier method was used to analyze the survival rate.Log rank test was used to evaluate the difference between the groups.Multivariate survival analysis was conducted using a Cox proportional hazard regression model with a backward stepwise procedure.Results The overall 1-,2- and 3-year survival rates were 29.8%,5.9% and 4.0%,respectively,with a median survival time of 8.0 months.The univariate analysis showed that ECOG PS,the interval between initial treatment and recurrence,the regimens of initial treatment and retreatment were independent prognostic factors.The multivariate analysis showed that the regimens of initial treatment and retreatment were independent prognostic factors. Retreatment methods significantly influenced the survival. The median survival time of chemoradiotherapy,radiation therapy alone,chemotherapy alone,EGFR-TKI and best supportive care were 13.0,7.0,6.0,4.0 and 3.0months,respectively ( P =0.000).Conclusions The prognosis of patients with locoregional recurrent esophageal cancer after curative treatment is poor.The main prognostic factors are the regimens of initial treatment and retreatment.Multimodal treatment including radiotherapy and chemotherapy may improve the long-term survival of the patients.